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OBJECTIVES: Administering steroids before cardiopulmonary bypass in pediatric heart surgery modulates
systemic inflammatory response syndrome and improves postoperative recovery. However, the use of steroids
aggravates hyperglycemia, which is associated with a poor prognosis. Adult patients with systemic
inflammatory response syndrome usually evolve with hyperglycemia and high insulin levels, whereas .90%
of pediatric patients exhibit hyperglycemia and low insulin levels. This study aims to determine: A) the
metabolic and inflammatory factors that are associated with hyperglycemia and low insulin levels in children
who underwent cardiac surgery with cardiopulmonary bypass and who received a single high dose of
methylprednisolone and B) the best predictors of insulin variation using a mathematical model.
METHODS: This preliminary study recruited 20 children who underwent heart surgery with cardiopulmonary
bypass and received methylprednisolone (30 mg/kg) immediately after anesthesia. Among the 20 patients
initially recruited, one was excluded because of the absence of hyperglycemia and lower insulin levels after
surgery. However, these abnormalities were confirmed in the remaining 19 children. The C-peptide, CRP, IL-6,
and adrenomedullin levels were measured before surgery, immediately after cardiopulmonary bypass, and on
the first, second, and third days after cardiac surgery.
RESULTS: IL-6, CRP, and adrenomedullin increments were observed, whereas the C-peptide levels remained
within reference intervals.
CONCLUSION: The multiple regression model demonstrated that in addition to age and glycemia (two well-
known factors that are directly involved in glucose metabolism), adrenomedullin and IL-6 levels were
independent factors associated with lower insulin concentrations. These four parameters were responsible for
64.7% of the observed insulin variances. In addition, the fact that C-peptide levels did not fall together with
insulin could have grounded the medical decision not to administer insulin to patients.
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& INTRODUCTION
Metabolism and immunity are closely associated; there-
fore, a systemic inflammatory response syndrome (SIRS)
produces and activates multiple proteins, including CRP,
and inflammatory cascade-releasing cytokines, such as IL-6.
Studies have demonstrated that IL-6 is increased earlier and
returns to baseline levels more rapidly than CRP in SIRS.
However, CRP levels are routinely measured in hospital
laboratories because of their multiple clinical applications,
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e.g., evaluating cardiac risk and detecting inflammation and
infection, whereas IL-6 is currently used as a research tool
(1).
Cardiac surgery with cardiopulmonary bypass (CPB)
triggers systemic inflammatory response syndrome (SIRS)
and evolves with hyperglycemia and insulin resistance in
adults, whereas .90% of children exhibit hyperglycemia
accompanied by low insulin levels (2,3).
Insulin is synthesized as preproinsulin and turned into
proinsulin. Proinsulin is then converted to insulin and C-
peptide and stored in granules that await release on demand.
C-peptide is secreted into the bloodstream in equimolar
amounts with insulin in response to blood glucose levels (4).
A single high dose of methylprednisolone (MP) is
routinely used in the majority of pediatric heart surgery
centers to blunt SIRS; however, MP aggravates hyperglyce-
mia (5,6), which is associated with a poor prognosis (7,8).
Verhoeven et al. (2011) studied 49 children undergoing
cardiac surgery and analyzed their blood glucose, insulin,
lactate, cortisol, ACTH, IL-6, and IL-10 levels before surgery,
immediately after surgery, and 12 h and 24 h after surgery.
Glucocorticoids were administered to 65% of the children,
and this administration was the main factor associated with
hyperglycemia, which was observed in 52% of the children
after surgery. However, hyperglycemia disappeared spon-
taneously without insulin therapy after 24 h in 94% of
children, which supported the results of other studies (9).
Because the postoperative morbidity was low in the study
group, the authors concluded that the positive effects of
glucocorticoid administration outweighed the adverse
effects of iatrogenic hyperglycemia.
There is a consensus on the usefulness of intensive insulin
therapy for glucose control to improve morbidity and
mortality rates in adult cardiac surgical patients (10). In
contrast, there have only been a few randomized controlled
studies in critically ill children (8,11). Agus et al. enrolled 980
children up to 36 months of age who were undergoing
cardiac surgery with CPB. The patients were randomly
assigned to either undergo tight glycemic control with
targeted blood glucose levels that ranged from 80-110 mg/
dL or receive standard care in the intensive care unit.
Continuous glucose monitoring was used to detect hypogly-
cemia. Overall, 444 of the 490 children (91%) who were
assigned to the tight glycemic control group received insulin
compared with 9 of the 490 children (2%) who were assigned
to receive standard care. Normoglycemia was achieved
earlier with tight glycemic control than with standard care
(6 h vs. 16 h, p,0.001) and was maintained in a greater
proportion of those patients (50% vs. 33%, p,0.001); however,
tight glycemic control was not associated with a significantly
decreased rate of associated infections (8.6 vs. 9.9 per 1,000
patient days, p= 0.67). Secondary outcomes, such as morbid-
ity, mortality, and multiple organ system failure, did not
differ significantly between the groups; therefore, it was
concluded that high-risk subgroups did not benefit from tight
glycemic control. In addition, 3% of the patients who were
assigned to undergo tight glycemic control had severe
hypoglycemia (blood glucose ,40 mg per deciliter) (12).
Considering the results of these studies, there is no consensus
on insulin use in children despite the frequent association
between hyperglycemia and cardiac surgery with CPB (7,8).
Many studies have been conducted on hyperglycemia
caused by SIRS in children with sepsis (5,6,13,14); however,
little is known about the factors that are involved in
regulating insulin in the context of SIRS triggered by cardiac
surgery with CPB and MP, which leads to hyperglycemia
and low insulin levels (5,6,15,16). The development of age-
appropriate immune modulatory interventions for prevent-
ing and treating SIRS abnormalities requires an investiga-
tion of the mechanisms that are responsible for the unique
pediatric inflammatory response to injury. Therefore, we
expanded our investigation of the clinical parameters that
can be used to monitor children after cardiac surgery with
CPB and MP. In addition to glycemia and CRP levels, which
are typically monitored in these children, we evaluated
insulin, IL-6, and adrenomedullin (ADM) levels. ADM is a
novel powerful vasodilating peptide that acts as an immune
modulator with bactericidal activity and as an inflammation
marker during SIRS with or without infection (17). In
addition, monitoring ADM levels is important due to its
capacity to inhibit insulin release through a direct action on
pancreatic b-cells (18,19). The ability of ADM to act
specifically on insulin release supports its use as a marker
in this type of pediatric patient.
Adult and pediatric patients differ according to insulin
levels after a hyperglycemic stimulus that is triggered by
SIRS and aggravated by MP. Additionally, there is no
consensus on the routine administration of exogenous insulin
to these pediatric patients. Therefore, we investigated
children who were subjected to cardiac surgery with CPB
and MP and who presented with hyperglycemia and low
insulin levels. We monitored blood glucose, insulin, C-
peptide, CRP, IL-6, and ADM levels to improve our under-
standing of the metabolic and inflammatory factors that are
involved in glucose regulation in these children and
determine the best predictors of insulin variance based on a
mathematical model.
& MATERIALS AND METHODS
After written informed consent was obtained from their
legal guardians, 20 children from the Heart Institute in the
School of Medicine at the University of Sa˜o Paulo, Brazil
were enrolled in the study. The inclusion criteria included
the presence of ventricular or atrial defects that required
surgical correction with CPB, aged over one year, the
presence of hyperglycemia and a decrease in insulin levels
after surgery. The exclusion criteria included the presence of
an infection one month before surgery, pre-existing endo-
crine diseases, abnormal glucose and/or insulin values
before the study, the need for insulin administration during
the hospital stay or for corticosteroids up to 30 days before
surgery, renal failure, pulmonary hypertension or conges-
tion, the need for diuretics or oxygen therapy, overt cardiac
failure, an inability to provide blood samples for all of the
laboratory tests during the five study time points, and the
refusal of parents or legal guardians to participate.
Anesthetic procedures, surgical procedures,
methylprednisolone administration and
postoperative care
On the day of surgery, the children received midazolam
(0.5 mg.kg-1) as premedication 30 minutes before surgery.
Anesthesia was induced and maintained with 2.0% sevo-
flurane inhalation and a target-controlled infusion system of
remifentanil (0.20 mg.kg-1.min-1). Then, an esophageal ther-
mometer, an indwelling bladder catheter, a 22G-24G arterial
catheter (right radial artery) and a central venous line (right
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internal jugular vein) were inserted. Arterial and central
venous blood pressure, core temperature, heart rate, oxygen
saturation and remifentanil dosing were continuously
recorded. Intraoperative mechanical ventilation was set
using pressure control ventilation with airway pressure (15-
10 cmH2O) to achieve a tidal volume of 8-10 mL.kg
-1, a PEEP
of 5 cmH2O, an inspiratory oxygen fraction of 0.6 and an
inspiratory time of 33%. The respiratory rate was adjusted to
maintain end-tidal CO2 at 35 cmH2O.
All of the patients received 30 mg.kg-1 of MP and
30 mg.kg-1 of cefuroxime immediately after anesthesia was
induced.
After sternotomy and systemic intravenous anticoagula-
tion with 400 U/kg of heparin, large bore aortic, superior and
inferior vena cava cannulas were inserted. Non-pulsatile CPB
was performed using a hollow fiber membrane oxygenator
(Terumo CapioxC RX05 Cardiovascular Systems, Ann Arbor,
MI, USA) with uncoated polyvinyl chloride bypass tubing
and a non-occlusive roller pump. Hypothermia (28-32 C˚) was
induced in all of the patients. The CPB circuit was primed
with normal saline, mannitol, sodium bicarbonate, calcium
chloride, heparin and red blood cells to achieve a hematocrit
of 20%. The circuit volumes were 450 mL for the patients
,10 kg, 800 mL for the patients 10-15 kg and 1.0-1.2 L for the
patients .15 kg. The pump flow rates were 200 mL/kg for
the children ,5 kg, 150 mL/kg for the children between 5
and 9 kg, 125 mL/kg for the children between 10 and 17 kg,
and 100 mL.Kg-1 for the children .17 kg. After initiating
CPB, hypothermia (28-32 C˚) was induced in all of the
patients. An initial dose of 30 mL.kg-1 was used to induce
cardioplegia, followed by 10 mL.kg-1 every 10-20 minutes. At
the end of CPB, the vascular cannulas were removed and
anticoagulation was reverted with protamine sulfate.
Vasoactive drugs were infused at the discretion of the
attending anesthesiologist. The same surgical team per-
formed all of the procedures.
After surgery, the patients were transferred to the
Pediatric Intensive Care Unit (PICU). The patients were
weaned from the vasoactive drugs within the first 12 h after
surgery. Fluids were restricted to 30 mL/kg/d during the
first 24 h and increased to 60 mL/kg/d while the glucose
infusion rate was maintained at 2 mg.kg -1.min.-1.
Blood sampling and laboratory tests
An initial blood sample (basal time, BT) was collected from
a peripheral vein to determine the pre-surgical glycemia,
insulin, C-peptide, IL-6, CRP, and ADM values. Intra-
operative and postoperative blood samples were taken using
a catheter after CPB (ACPB) and on the first (POD1), second
(POD2), and third postoperative days (POD3) to analyze the
parameters. The dead space and the extension of the
indwelling venous catheter were cleared before blood
collection.
Plasma glucose (glycemia) was analyzed using the
hexokinase enzymatic method. Normal glucose levels
ranged from 60-125 mg.dL-1 (5).
Serum insulin levels were determined using a lumines-
cence enzyme immunoassay (Auto DELFIA automatic
immunoassay system, Perkin Elmer Life and Analytical
Sciences, Shelton, CT, USA). The reference interval was 2-
16 mU.L-1, and the detection limit was 3 mU.L-1.
Serum C-peptide levels were determined using a lumi-
nescent immunoassay (Immulite; Diagnostic Products, Los
Angeles, California, USA), and the normal range varied
from 1.1-4.4 ng.mL-1.
Serum CRP concentrations were determined using immu-
nonephelometry (nephelometer-2, Dade-Behring, La De´-
fense, France); the reference values were #5.0 mg.L-1.
Serum IL-6 levels were measured using a highly sensitive
EIA kit (Human Interleukin-6 Quantikine HS ELISA, R&D
Systems, Minneapolis, USA). The detection limit was
0.7 pg.mL-1.
Serum ADM concentrations were measured using the EIA
Kit from Phoenix Pharmaceuticals (Inc., Belmont, CA). The
detection range was 0.01-100 ng.mL-1, and the reference
interval was ,0.5 ng.mL-1.
Statistical analysis
The normal distribution of data was studied using the
Skewness, Kurtosis and Shapiro-Wilk tests (20). For mea-
surements over time, the Friedman analysis of variance test
was used to establish the overall group differences. Multiple
comparisons were performed using the Wilcoxon test.
The variation in the insulin concentrations was tested for
normality. Because the distribution was normal, a multiple
regression analysis with the Bonferroni correction was used
to assess the independent variables associated with low
insulin levels.
To evaluate the influence of glucose, C-peptide, CRP, IL-6,
and ADM on insulin levels after cardiac surgery with CPB
and MP, the concentration variations were calculated as the
difference between the first postoperative day (POD1) levels
and the baseline time (BT) levels (i.e., POD1-BT).
All of the variables were initially tested, and a backward
stepwise elimination of the variable with the largest p-value
was performed at each step to enable the model to be
refitted. In each subsequent step, the least significant
variable was removed from the model until all of the
remaining variables had individual p-values,0.05.
The IL-6 and CRP concentrations both increased; there-
fore, we selected one inflammation marker (IL-6) to avoid
artificial increments of R2.
The variation in the glucose levels (glycemia) and the
patients’ ages (in months) were arbitrarily included in the
model irrespective of their p-values because of their central
roles in pancreatic function and insulin regulation.
The fitness in each step was assessed using the adjusted
coefficient of determination (adjusted R2).
The collinearity and multicollinearity among the inde-
pendent variables were tested using the variance inflation
factor (VIF). The beta coefficients (ß) of the variables were
used to express the effect of the different variable sizes in
the final model. The coefficients of semi-partial determina-
tion (spR2) were assessed to evaluate the relative impor-
tance of each variable with respect to the other variables.
The limit of agreement between the observed and predicted
insulin variations, which were obtained using the multiple
regression equation, was performed according to the
method proposed by Bland and Altman (21).
The data were expressed as the mean¡standard devia-
tion or the median [25th and 75th percentiles] according to
the data distribution. In the boxplots, the bottom and top of
the box were the 25th and 75th percentiles, respectively. The
line within the box was the median, and the lower and
upper whiskers were the 1.5 IQR of the lower quartile and
the 1.5 IQR of the upper quartile, respectively (22). The
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statistical analyses were performed using the STATA 11.1
statistical package (StataCorp., College Station, Texas, USA).
& ETHICS
This study was approved by the Institutional Ethics
Committee (protocol CAPPesq number 675/05).
& RESULTS
The study group consisted of 19 children, ten girls and
nine boys, after excluding one child because of the absence
of hyperglycemia and lower insulin levels after surgery. The
study group was a convenience sample that was limited by
the number of children who met the inclusion criteria of the
study, whose parents or legal guardians agreed to partici-
pate and who underwent five successful blood samplings.
We recruited children with congenital heart defects of
moderate severity who were clinically stable to ensure that
the five blood samplings would not damage their health.
The homogeneity of the participant heart disease was
essential to ensure the internal and external validity of the
study and allow for the extrapolation of the data to
populations of children with congenital heart defects of
moderate severity who were subjected to cardiac surgery
with CPB and MP in pediatric intensive care units.
The mean age of the patients was 39¡16 months, and the
mean weight was 14¡3.8 kg. Atrial and ventricular defects
were corrected in 10 and 9 children, respectively. The mean
CPB duration was 55¡14 min., and the mean aortic cross-
clamp length was 25¡6 min. None of the children needed
inotropic support or experienced surgical complications.
The patients were all discharged from the pediatric
intensive care unit (PICU) within 72 hours.
Many parents and legal guardians did not consent to
participate, primarily because of the volume of blood
samples that were needed for the five study time points
and/or the fear of increased risks to their children. In
addition, this study was limited by its budget because most
of the exams are not routinely performed in hospital
laboratories, and several exams needed to be tested in
triplicate to comply with the manufacturers’ instructions,
particularly the enzyme immunoassays that were used to
evaluate IL-6 and ADM.
Figure 1 shows the insulin, glycemia, C-peptide, ADM,
IL-6 and CRP levels throughout the study period.
Compared with the BT values (p,0.05), the insulin levels
at the post-CPB time point and at the POD1 time point had
decreased by 72% and 74%, respectively. On POD2 and
POD3, the insulin levels increased by 47% with respect to
the BT values (p = NS). Glycemia increased significantly
from the BT time point to the POD1 time point (87 mg.dL-1
[68-88] to 172 mg.dL-1 [155-207], p,0.05) but returned to the
BT levels on POD3. The C-peptide levels (Figure 1) did not
significantly change. The ADM levels at the BT time point
were slightly higher than normal, and 323% increments
were observed on POD1 (p,0.05); however, the levels
returned to BT levels on POD3. There was a significant
increase in the IL-6 and CRP levels, which peaked on POD1
and returned to BT levels on POD3.
During the fitting process, several variables were
removed from the initial model (step-by-step) in the
following order: 1) the variation in the C-peptide values,
2) the aortic cross-clamp duration, and 3) the CPB duration.
Table 1 shows the final multiple regression model that was
used to predict insulin levels, including patient age
expressed in months and the variations in the glycemia,
ADM and IL-6 values. Taken together, these parameters
explained 64.7% of the insulin reduction on POD1, F (4,
14) = 9.22, p,0.001. The following four tested variables
reached statistical significance and were successfully corre-
lated with insulin variation according to their semipartial
R2: age (0.55, p,0.001), glycemia variation (0.17, p = 0.01),
ADM variation (0.18, p = 0.009), and IL-6 variation (0.2,
p = 0.007).
The diagram displayed on the left side of Figure 2 shows
the observed insulin values and the predicted values that
were calculated using the multiple regression equation. The
following final equation was used to predict insulin
variation (mU.L-1):
{16:3z0:14|agez0:03|glycemia mg:dL{1
 
z
0:29|ADM ng:mL{1
 
{0:17|IL{6 pg:mL{1
 
,
where -16.3 was a negative constant, patient age was
expressed in months and the glycemia, ADM and IL-6
variations were the difference between the POD1 and BT
values. The diagram displayed on the right side of Figure 2
shows that the 95% limit of agreement for the observed and
predicted insulin values according to the Bland and Altman
analysis was within the interval -2.76 to+2.76 mU.L-1.
& DISCUSSION
A better understanding of the complex interactions
between metabolism and inflammation in critically ill
children, such as children with congenital heart defects of
moderate severity, will lead to appropriate general and
metabolic support for these patients.
In this study, all 19 children had hyperglycemia and low
insulin levels caused by SIRS, which was induced by cardiac
surgery with CPB and attenuated by MP. The insulin
resistance state, which is characterized by decreased periph-
eral use of glucose in skeletal muscles and the liver (13), is
more prone to occur in the context of prolonged hypergly-
cemia that is caused by multiple mechanisms, including the
counter regulation of gluconeogenesis and glycogenolysis
and the downregulation of glucose transporters (23).
To our knowledge, this is the first study that has
demonstrated variations in insulin concentrations and their
association with inflammatory markers and other factors in
pediatric cardiac surgery with CPB and MP, which leads to
SIRS, hyperglycemia and low insulin levels. This study has
several limitations, such as the lack of MP evaluation on the
study time points, although it is well-known that MP effects
are exerted during the first 12 h after surgery (24). In
addition, most of the findings in this study occurred at the
ACPB time point and persisted until the POD2 and POD3
time points, according to the parameter. Another limitation
was the convenience sample, which was composed of only
19 patients who were evaluated over time (five study time
points). However, age, glycemia, and the IL-6 and ADM
levels of the patients reached strong statistical significance;
therefore, the results indicate that these four parameters in
the proposed mathematical model were consistently corre-
lated with insulin variation in this study.
In adult patients with SIRS, hyperglycemia is frequently
associated with high insulin and C-peptide levels because of a
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peripheral resistance to insulin (2). In contrast, Vignewaran et
al. described reduced insulin levels in children after cardiac
surgery with CPB, which supported our findings; however,
the authors did not monitor the other laboratory parameters
(25). Bialkowski et al. reported hyperglycemia accompanied
by insulin reduction during and after cardiac surgery with
CPB in children; however, the authors did not use MP. In
contrast to our findings, the C-peptide levels were reduced in
the study along with insulin levels (3), most likely because of
more pronounced and/or prolonged hyperglycemia.
As expected in pediatric patients after cardiac surgery
with CPB and MP, glycemia levels increased and insulin
levels decreased in all 19 patients and reached maximum
and minimum levels at the POD1 time point, respectively.
The glycemia and insulin levels returned to baseline levels
at the POD3 and POD2 time points, respectively. These
findings were in agreement with those of other studies (26).
During this study, all of the patients had glycemia that
exceeded 125 mg.dL-1, which was the threshold adopted in
this study; however, these values were higher than 150 mg/
Figure 1 - Insulin, glycemia, C-peptide, ADM, IL-6, and CRP levels throughout the study period. The shaded area in each diagram
represents the normal range of the test. *indicates a statistically significant difference between the value at the study time point and
the baseline value (Wilcoxon).
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dL-1. None of the patients received insulin, most likely
because the hyperglycemia levels were not persistently
high. Decisions related to patient care were made by the
attending physicians at the Heart Institute without inter-
ference from the researchers.
In this study, it is likely that the main factor associated
with hyperglycemia was a single high dose of MP, which
was administered in all of the children; this result supported
previous data (5).
The decreased insulin response after cardiac surgery with
CPB in these children may be caused by the greater
vulnerability to beta cell dysfunction that is observed in
critically ill children compared with adults. Therefore,
adults who are subjected to cardiac surgery with CPB
evolve with hyperglycemia and resistance to insulin,
whereas insulin concentrations are reduced in the majority
of children. Preissig and Rigby (8) hypothesized that beta
cells are extremely sensitive to rapid physiological changes;
therefore, these cells may become dysfunctional if these
changes occur quickly and exceed a certain threshold.
Changes may be induced by multiple factors, such as
hypothermia during CPB, vasopressors to maintain blood
pressure, elevations of proinflammatory cytokines, includ-
ing IL-6, and the use of glucocorticoids, such as MP
(1,9,12,25). Excluding the use of vasopressors, all of these
factors were present in this study. The acute and temporary
nature of the physiological disturbance that is induced by
SIRS may explain the low insulin levels and the unaltered C-
peptide levels. In this context, the C-peptide is a more stable
marker of beta cell function than insulin because of its
longer half-life, lower first-pass hepatic extraction and lack
of adherence to the CPB circuit (4,27). Because of this
stability and the temporal nature of the hyperglycemia that
was triggered by SIRS and aggravated by MP in this study,
the C-peptide levels were not as reduced as the insulin
levels; therefore, this marker could not be used to predict
insulin behavior. Nevertheless, the monitoring of C-peptide
levels was useful and could have led to the medical decision
not to administer insulin to patients.
Regarding the CRP and IL-6 levels, there were similar
variations in these two parameters, including a significant
increment after surgery and a return to baseline levels at the
POD3 time point. According to the multivariate analysis, the
insulin reduction was directly proportional to patient age
and glycemia, whereas the ADM and IL-6 increments
followed the magnitude of inflammation (28). To elaborate
the mathematical model, we arbitrarily included the IL-6
levels instead of the CRP levels. However, these markers
demonstrated similar behavior. Because only CRP levels are
routinely evaluated after cardiac surgery in pediatric
intensive care units, this parameter could replace the IL-6
levels in the model.
Several studies in adults have found that ADM concentra-
tions increased during CPB (17,29). Komai et al. were the first to
describe increased ADM levels in 14 children after cardiac
surgery with CPB (29). This trend was later confirmed by
Szekely et al., Takeuchi et al. and Sekine et al. (18). These
authors found that ADM can inhibit insulin/C-peptide
exocytosis via the activation of G proteins that are located on
the insulin/C-peptide cellular receptor. We observed a slight
elevation in the ADM concentrations at the BT time point;
however, the children in our study were not healthy because of
Table 1 - Statistical analysis results show the coefficient (Coef), the standard error (Std err.), the p value, the 95%
confidence interval, the variance inflation factor (VIF), the 1/VIF, the ß coefficient, and the coefficients of the
semipartial determination (spR2) of the four independent variables (age, glycemia, ADM and IL-6) that were
significantly correlated with insulin variation.
Coef. Std. Err. p-value 95% CI VIF 1/VIF ß coef. SP R2
Age (months) 0.14 0.03 ,0.001 0.08 - 0.19 1.23 0.81 0.82 0.55
Glycemia variation (mg.dL-1) 0.03 0.01 0.01 0.01 - 0.05 1.18 0.84 0.43 0.17
ADM variation (ng.mL-1) 0.29 0.1 0.009 0.09 - 0.5 1.09 0.92 0.43 0.18
IL-6 variation (pg.mL-1) -0.17 0.05 0.007 -0.28 - -0.05 1.03 0.97 -0.48 0.2
Intercept -16.34 1.59 ,0.001 -19.74 - -12.94
Figure 2 - The diagram on the left shows the observed insulin values and the predicted values that were calculated using the multiple
regression equation. The diagram on the right shows that the 95% limit of agreement for the observed and predicted insulin values
was within an interval of -2.76 to+2.76 mU.L-1 (Bland and Altman).
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previous heart conditions, and this finding was expected. In
addition, a strong ADM increment occurred after CPB, which
was accompanied by a decrement in insulin levels but not in
C-peptide concentrations. The latter is secreted in equimolar
amounts with insulin; therefore, ADM may have temporarily
affected insulin release but did not inhibit C-peptide exocytosis
or the inhibition was not strong enough to reduce the C-peptide
concentrations in this study. We expected to observe C-peptide
levels below the reference interval.
The results of this study were based on a convenience
sample of 19 children; however, the strict application of the
study inclusion criteria and the homogeneity of the patient
heart conditions enabled us to evaluate the role of all of the
laboratory parameters during SIRS. Therefore, the semipar-
tial R2 analysis indicated that patient age, glycemia, and the
ADM and IL-6 levels were independent factors that were
associated with insulin variation. These findings were
confirmed in the multiple regression analysis with the
Bonferroni correction, which demonstrated that these four
parameters were responsible for 64.7% of the observed
insulin variance. Although significant, this percentage
indicates that childhood SIRS that is induced by cardiac
surgery with CPB and MP and leads to hyperglycemia and
low insulin levels is a complex process that involves more
factors than those investigated in this study.
In our patients, the insulin levels decreased, but there
were no significant variations in the C-peptide levels during
the study. Therefore, the insulin levels were normal in these
children, which indicated that hyperglycemia did not
persist for a long time period because glycemia returned
to BT levels at the POD3 time point, and the insulin
concentrations returned to BT levels one day earlier (POD2).
Considering the potential hazards of iatrogenic hypoglyce-
mia that is caused by exogenous insulin and the deleterious
effects of hyperglycemia in these patients, insulin adminis-
tration should be considered when a concomitant reduction
in the insulin and C-peptide levels occurs in children with
sustained hyperglycemia after cardiac surgery with CPB
and MP. Therefore, the equation proposed in this study,
modified or not by the replacement of IL-6 by CRP, and of
ADM for another inflammation or metabolic marker could
be useful to predict most of the insulin variation in pediatric
intensive care units. In addition, the monitoring of insulin
and C-peptide levels in parallel with glycemia is useful in
the medical decision not to administer insulin to patients.
Therefore, insulin and C-peptide exams are advised for
these patients.
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